标题 | 盐酸右美托咪定联合瑞芬太尼在骨科手术中的麻醉中的应用分析 |
范文 | 王利敏 [摘要] 目的 探討分析盐酸右美托咪定联合瑞芬太尼在骨科手术中的麻醉效果及不良反应。方法 从该院2018年3月—2019年2月收治的骨科手术患者中方便选取92例作为该次研究对象,分为两组,其中2018年3月—2018年8月46例为对照组,给予瑞芬太尼联合丙泊酚进行麻醉;2018年9月—2019年2月46例为观察组,给予盐酸右美托咪定联合瑞芬太尼进行麻醉。比较两组患者的麻醉效果和不良反应。结果 两组的麻醉效果相比,对照组麻醉时间(6.75±1.70)min,观察组麻醉时间(5.29±1.08)分,差异有统计学意义(t=5.783,P=0.019);对照组拔管时间(9.78±2.30)min,观察组拔管时间(7.33±2.03)min,差异有统计学意义(t=6.437,P=0.023);对照组VAS评分(2.41±0.23)分,观察组VAS评分(1.53±0.42)min,差异有统计学意义(t=12.918,P=0.036)。两组的不良反应情况相比,对照组发生低血压2例、躁动3例、呼吸抑制3例、呼吸道梗阻3例,不良反应发生率为23.91%(11/46);观察组发生低血压1例、躁动2例、呼吸抑制1例、呼吸道梗阻1例,不良反应发生率为10.86%(5/46),差异有统计学意义(χ2=5.878,P=0.002)。 结论 盐酸右美托咪定联合瑞芬太尼应用于骨科手术中麻醉效果好,可显著降低患者不良反应发生率,安全系数更高,值得临床推广应用。 [关键词] 盐酸右美托咪定;瑞芬太尼;骨科手术;麻醉效果;不良反应 [Abstract] Objective To investigate and analyze the anesthetic effect and adverse reactions of dexmedetomidine hydrochloride combined with remifentanil in orthopedic surgery. Methods From the orthopedic surgery patients admitted in the hospital from March 2018 to February 2019, 92 cases were convenient selected as the research object and divided into two groups, of which 46 cases were from March 2018 to August 2018 as the control group. Anesthesia was given to remifentanil combined with propofol; 46 cases from September 2018 to February 2019 were the observation group, and dexmedetomidine hydrochloride combined with remifentanil was anesthetized. The anesthetic effects and adverse reactions of the two groups of patients were compared. Results Compared with the anesthesia effect of the two groups, the anesthesia time of the control group was (6.75±1.70) minutes, and the anesthesia time of the observation group was (5.29±1.08) minutes. Tube time (9.78±2.30) minutes, observation group extubation time (7.33±2.03) minutes, the difference was statistically significant(t=6.437,P=0.023); control group VAS score (2.41±0.23) points, observation group VAS score was (1.53±0.42)points, and the difference was statistically significant(t=12.918,P=0.036). Compared with the adverse reactions in the two groups, 2 cases of hypotension, 3 cases of agitation, 3 cases of respiratory depression, and 3 cases of respiratory obstruction occurred in the control group. The incidence of adverse reactions was 23.91% (11/46), 2 cases of agitation, 1 case of respiratory depression, 1 case of respiratory tract obstruction, the incidence of adverse reactions was 10.86% (5/46), and the difference was statistically significant(χ2=5.878,P=0.002). Conclusion Dexmedetomidine hydrochloride combined with remifentanil has a good anesthetic effect in orthopedic surgery, it can significantly reduce the incidence of adverse reactions in patients, and has a higher safety factor, which is worthy of clinical application. 该次研究中两组的不良反应情况相比,对照组发生低血压2例、躁动3例、呼吸抑制3例、呼吸道梗阻3例,不良反应发生率为23.91%(11/46);观察组发生低血压1例、躁动2例、呼吸抑制1例、呼吸道梗阻1例,不良反应发生率为10.86%(5/46),差异有统计学意义(P<0.05)。该次研究结果证实,在不良反应发生率方面观察组均优于对照组,这与胡明秀等[8]的研究中,选取选择东莞市麻涌人民医院收治的120例骨科手术患者,随机分为为观察组和对照组,各60例,结果显示观察组实施盐酸右美托咪定联合瑞芬太尼麻醉不良反应发生率11.7%优于对照组实施瑞芬太尼联合丙泊酚麻醉不良反应发生率25.0%,这与该次研究结果基本一致。 綜上所述,盐酸右美托咪定联合瑞芬太尼应用于骨科手术中麻醉效果显著,安全系数高。 [参考文献] [1]? 朱俊海.盐酸右美托咪定联合瑞芬太尼在骨科手术中的麻醉效果研究[J].基层医学论坛,2017,21(35):4971-4972. [2]? 秦文英.智宗协 盐酸右美托咪定联合瑞芬太尼在骨科手术中的麻醉效果[J].中国合理用药探索,2018,15(6):57-60. [3]? 李海燕,郑智文,杨兴,等.盐酸右美托咪定联合瑞芬太尼在骨科手术中的镇静效果及对患者血流动力学和呼吸功能的影响[J].现代生物医学进展,2018,18(3):532-536. [4]? 李海燕.观察盐酸右美托咪定联合瑞芬太尼在骨科手术中的麻醉效果[J].心理医生,2017,23(34):40-41. [5]? 陈铁忠.盐酸右美托咪定联合瑞芬太尼在骨科手术中的镇静效果观察[J].现代实用医学,2017,29(7):920-921. [6]? 盛李平,马艳红,宋水涛.α2-肾上腺素受体激动剂联合瑞芬太尼麻醉对骨科手术患者的影响[J].中国疗养医学,2018, 27(10):64-66. [7]? 贾衍杰.瑞芬太尼复合右美托咪定在心脏手术中的应用及对患者血流动力学的影响分析[J].中国现代药物应用,2018, 12(17):90-91. [8]? 胡明秀,陈汝康,付婵.盐酸右美托咪定联合瑞芬太尼在骨科手术中的应用效果观察[J].黑龙江医学,2018(42):778-780 (收稿日期:2019-12-19) |
随便看 |
|
科学优质学术资源、百科知识分享平台,免费提供知识科普、生活经验分享、中外学术论文、各类范文、学术文献、教学资料、学术期刊、会议、报纸、杂志、工具书等各类资源检索、在线阅读和软件app下载服务。